Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, et al.
Tropical Medicine and Health (2021) Vol. 49, Iss. 1
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022
Arindam Nandi, Simone Pecetta, David E. Bloom
EClinicalMedicine (2023) Vol. 57, pp. 101848-101848
Open Access | Times Cited: 133
Antimicrobial Peptides: From Design to Clinical Application
Chunye Zhang, Ming Yang
Antibiotics (2022) Vol. 11, Iss. 3, pp. 349-349
Open Access | Times Cited: 83
Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance
Yusuff Adebayo Adebisi
Globalization and Health (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Evaluation of the consumption pattern and efficacy of Linezolid in COVID-19 hospitalized patients in a hospital in Tehran-Iran
Ali Rostami, Morteza Izadi, Mohsen Saberi Isfeedvajani, et al.
DARU Journal of Pharmaceutical Sciences (2025) Vol. 33, Iss. 1
Closed Access | Times Cited: 1
COVID-19 and Antimicrobial Resistance: A Review
Yusuff Adebayo Adebisi, Aishat Jumoke Alaran, Melody Okereke, et al.
Infectious Diseases Research and Treatment (2021) Vol. 14
Open Access | Times Cited: 64
Repurposing phytochemicals as anti‐virulent agents to attenuate quorum sensing‐regulated virulence factors and biofilm formation inPseudomonas aeruginosa
Jatin Chadha, Kusum Harjai, Sanjay Chhibber
Microbial Biotechnology (2021) Vol. 15, Iss. 6, pp. 1695-1718
Open Access | Times Cited: 58
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Zikria Saleem, Brian Godman, Aislinn Cook, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 56
Sustainable development goals under threat? Multidimensional impact of COVID-19 on our planet and society outweigh short term global pollution reduction
Abdul Qadeer, Muchlison Anis, Zeeshan Ajmal, et al.
Sustainable Cities and Society (2022) Vol. 83, pp. 103962-103962
Open Access | Times Cited: 54
Prescribing Patterns of Antibiotics According to the WHO AWaRe Classification during the COVID-19 Pandemic at a Teaching Hospital in Lusaka, Zambia: Implications for Strengthening of Antimicrobial Stewardship Programmes
Steward Mudenda, Eustus Nsofu, Patience Chisha, et al.
Pharmacoepidemiology (2023) Vol. 2, Iss. 1, pp. 42-53
Open Access | Times Cited: 29
Antibiotic Utilization during COVID-19: Are We Over-Prescribing?
Nataša Bednarčuk, Ana Golić Jelić, Svjetlana Stoisavljević Šatara, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 308-308
Open Access | Times Cited: 28
Green valorization of end-of-life toner powder to iron oxide-nanographene nanohybrid as a recyclable persulfate activator for degrading emerging micropollutants
Mahmoud Samy, Kenneth Mensah, Esmail M. El‐Fakharany, et al.
Environmental Research (2023) Vol. 223, pp. 115460-115460
Closed Access | Times Cited: 28
Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications
Linda Siachalinga, Brian Godman, Julius Chacha Mwita, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 2179-2190
Open Access | Times Cited: 26
Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1843-1843
Open Access | Times Cited: 23
Multiresidue determination and predicted risk assessment of emerging contaminants in sediments from Kongsfjorden, Svalbard
Jasmin Rauseo, Francesca Spataro, Tanita Pescatore, et al.
The Science of The Total Environment (2024) Vol. 922, pp. 171156-171156
Closed Access | Times Cited: 8
Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications
Kiran Ramzan, Sameen Shafiq, Iqra Raees, et al.
Antibiotics (2022) Vol. 11, Iss. 6, pp. 789-789
Open Access | Times Cited: 33
Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020–2021: Practice Does Not Follow Policy
Ibrahim Franklyn Kamara, Ajay Kumar, Anna Maruta, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 7, pp. 4005-4005
Open Access | Times Cited: 31
The Implementation of National Action Plan (NAP) on Antimicrobial Resistance (AMR) in Bangladesh: Challenges and Lessons Learned from a Cross-Sectional Qualitative Study
Syed Masud Ahmed, Nahitun Naher, Samiun Nazrin Bente Kamal Tune, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 690-690
Open Access | Times Cited: 28
pH-triggered bio-inspired membranes engineered using sequential interpenetrating polymeric networks for tunable antibiotic and dye removal
Ria Sen Gupta, Nagarajan Padmavathy, Piyush Agarwal, et al.
Chemical Engineering Journal (2022) Vol. 446, pp. 136997-136997
Closed Access | Times Cited: 28
Persistence of resistance: a panel data analysis of the effect of antibiotic usage on the prevalence of resistance
Sakib Rahman, Aaron S. Kesselheim, Aidan Hollis
The Journal of Antibiotics (2023) Vol. 76, Iss. 5, pp. 270-278
Open Access | Times Cited: 20
The global antimicrobial resistance response effort must not exclude marginalised populations
Yusuff Adebayo Adebisi, Isaac Olushola Ogunkola
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 19
How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?
Natália Cassago Marcos Massarine, Gleyce Hellen de Almeida de Souza, Isadora Batista Nunes, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1374-1374
Open Access | Times Cited: 15
Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals
Amanj Kurdi, Najla Al Mutairi, Kirmanj Baker, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-12
Open Access | Times Cited: 5
Structure–Activity Relationship of Ciprofloxacin towards S-Spike Protein of SARS-CoV-2: Synthesis and In-Silico Evaluation
Sahil Kumar, Papiya Dey, Arup Kumar Pathak, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Investigating the Antibiotic Resistance Genes and Mobile Genetic Elements in Water Systems impacted with Anthropogenic Pollutants
Poonam Sharma, Namrata Pal, Manoj Kumawat, et al.
Environmental Research (2025), pp. 120814-120814
Closed Access
In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, et al.
Marine Drugs (2022) Vol. 20, Iss. 2, pp. 148-148
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top